Dr. Arun Chandavarkar

Non-Executive and Non-Independent Director

Arun Chandavarkar, Ph.D., is the Non-Executive and Non-Independent Director of Biocon Biologics Limited, a subsidiary of Biocon Ltd., and has been a member of the board of Biocon Biologics since its inception in 2016.

Previously, he served as the Managing Director of Biocon Biologics Ltd. from January 2021 to December 2022, Prior to becoming Managing Director, he held the position of Managing Director at Biocon Ltd. from April 2014 to November 2019 when he retired after a nearly three-decade-long career at Biocon.

Dr Chandavarkar was a part of the core team that led Biocon’s growth and strategy focused on improving access to high quality, affordable biopharmaceuticals and specialty medicines in chronic therapies such as diabetes, oncology and immunology. Under his leadership, Biocon has made significant investments in cutting-edge R&D and efficient, compliant operations that translated into a unique and differentiated product portfolio straddling fermentation-derived complex generics, biosimilars and novel biologics, all aimed at a worldwide patient population.

Dr Chandavarkar had graduated in Chemical Engineering from the Indian Institute of Technology (IIT), Mumbai and holds a Ph.D. in Biochemical Engineering from MIT, Cambridge, U.S.A

He served as Chairperson of the National Committee on Biotechnology of the Confederation of Indian Industry (CII) for the year 2016-17.